INTRODUCTION

18
P. aeruginosa is a ubiquitous Gram-negative opportunistic pathogen that has the ability to 19 survive in a wide range of natural reservoirs (Fito-Boncompte et al., 2011) . It is involved in 20 many types of human infections in the community as well as health care settings (Kapoor et 21 al., 2011; Ivanov et al., 2011) . Eighty percent of cystic fibrosis (CF) patients are infected with 22 P. aeruginosa. CF and immunocompromised patients are more vulnerable to sepsis and 23 pneumonia caused by this pathogen (Bridier et al., 2011; Kapoor et al., 2011) , which can 24 also cause contact lens associated infections (Stewart et al., 2011) . 25
An important characteristic of P. aeruginosa is its capability to confer resistance to several 26 categories of antibiotics (Kapoor et al., 2011; Tian et al., 2011) . Intrinsic mechanisms of 27 antimicrobial tolerance include the expression of β-lactamases and efflux pumps, and 28 decreased permeability of the outer membrane. It also has certain characteristics enabling it 29 to invade its host causing serious infections. The type III secretion system allows the 30 organism to inject secreted toxins directly into the eukaryotic cytoplasm (Kipnis et al., 2006) . 31
The exs genes encode four effector proteins: ExoS, ExoT, ExoU and ExoY (Feltman et al., 32 2001) . ExoU is considered a cytotoxin needed for full virulence of P. aeruginosa. Both ExoS 33
and ExoU cause cytotoxicity in epithelial cells (Hauser et al., 1999) . 34
Molecular typing of P. aeruginosa has become important in identifying cross-infections in 35 hospitals and specifically in CF centers, thus helping to control transmission means. Pulsed-36 field gel electrophoresis (PFGE) has a high discriminatory power making it a reliable 37 standard for DNA fingerprinting of isolates to identify or confirm outbreak situations. 38
This work aims at the typing and characterization of 100 P. aeruginosa isolates collected and 39 looking at correlations between banding patterns, drug resistance and exotoxin production. 40 41
MATERIALS AND METHODS
43
Clinical isolates
44
A total of 100 P. aeruginosa isolates were collected from the American University Hospital 45 which provides medical care for patients across Lebanon, in the period between March and 46 November of 2007. The isolates were mainly recovered from tracheal aspirates (28%), urine 47 (21%), sputum (16%), pus (11%), and wound (7%). The remaining isolates were distributed 48 among blood (3%), bronchial washing (3%), ear (3%), bile (2%), pleural fluid (1%), catheter 49 (1%), urethral discharge (1%), and other tissues (3% Studying effectors released by the type III secretion system including exoU and exoS 107 revealed that 48% of the isolates harbored exoS toxin gene and 46% the exoU, with 3% 108 having both and 8% having none. Thirty six and 38% of the isolates harboring exoU and 109 exoS respectively were additionally MDR. Twenty eight of the isolates were recovered from 110 tracheal aspirates out of which 2 were MDR and positive for both toxin genes. It is 111 noteworthy that a high percentage of the isolates showing resistance to each of the tested 112 antimicrobial agents, were also found to be positive for ExoS and/or ExoU and at the same 113 time MDR (Fig. 2) . 114 A variety of factors have been described to contribute to the virulence detected in P. 
PFGE
151
DNA fingerprinting by PFGE of genomic DNA after digestion with SpeI resulted in distinct 152 genomic fingerprints among the 100 examined isolates. None of the isolates were 153 genetically identical with 100% similarity index. Eighty-three isolates were found to be 154 genetically different where less than 80% band similarity was detected (Tenover et al., 155 1995) . The remaining 16 isolates were classified in clones that belonged to different groups 156 and only one of the isolates could not be typed. 157
When the different fingerprints were compared on a dendogram (Fig. 3) , 45 groups 158 emerged; majority of these groups consisted of strains with pattern similarity greater than 159 60%. No significant correlation could be seen between the pulse field pattern, resistance and 160 secreted toxins. 161 PFGE revealed that most of the isolates had distinct PFGE patterns where the similarity was 162 below 80%. This however, was consistent with other studies; such heterogeneity indicates 163 endogenous origin of Pseudomonas infections of unrecognized molecular clusters (Bertrand 164 et al., 2001; Waters et al., 2004) and the existence of a non-clonal population structure (Maatallah et al., 2011) . Very closely related isolates in this study, having more than 90% 166 genetic similarity index were shown to be recovered from the same patient. This indicated 167 also that patients being admitted were not harboring or acquiring other clones of P. 168 aeruginosa, a result also reported in a previous study by Heo et al. (2008) . 169
Finding a correlation between PFGE patterns and site of infection could be of interest 170 especially with outbreak cases. However, in this study, where molecular typing showed vast 171 differences among the isolates, it was unlikely to find any significant correlation between 172 PFGE groups and site of infection. Nevertheless, group A17 consisted of 5 isolates all 173 recovered from tracheal aspirates with all being multi drug resistant. The association 174 between this group and respiratory tract infections was noteworthy, specially that this type of 175 infections in the hospital settings, were previously reported as being the most common type 176 in intensive care units (ICU) (Agodi et al., 2007) . Other sites of infection, such as wounds, 177 ear, blood, and catheter were sporadic among the groups. However, those isolates were 178 few; hence data may not be sufficient to correlate with their corresponding PFGE profiles. 179 
